Journal article

Cost savings with a novel algorithm for early detection of systemic sclerosis-related pulmonary arterial hypertension.

Alannah QUINLIVAN, Susanna Proudman, Joanne Sahhar, Wendy Stevens, Mandana Nikpour, undefined on behalf of the Australian Scleroderma Interest Group (ASIG)

International Medical Journal | Japan International Cultural Exchange Foundation | Published : 2019


Pulmonary Arterial Hypertension (PAH) is an important cause of death and disability in Scleroderma (SSc) patients. Yearly screening of all SSc patients with transthoracic echocardiography (TTE) is recommended in international guidelines and currently utilised by the Australian Scleroderma Interest Group (ASIGSTANDARD). Due to the limitations of TTE, the Australian Scleroderma Interest Group (ASIG) developed a new screening algorithm (ASIGPROPOSED) utilizing a serum biomarker, NT-proBNP, in place of TTE, which has been shown to be equally accurate as the current algorithm. The aim of this study was to compare the cost of these two algorithms. The new algorithm resulted in significant yearly c..

View full abstract